Source: European Commission Joint Research Centre – Publication date: January 2010
The ENRHES project has performed a comprehensive and critical scientific review of the health and environmental safety of fullerenes, carbon nanotubes, metal and metal oxide nanomaterials. The review considers sources, pathways of exposure, the health and environmental outcomes of concern, in the context illustrating the state-of-the-art in the field and informing the regulation of the potential risks of engineered nanoparticles.
Source: Project on Emerging Nanotechnologies – Publication date: May 2007
As the Environmental Protection Agency (EPA) recently stated, nanotechnology has evolved from a futuristic idea to watch to a current issue to address. A new report considers various oversight tools for dealing with nanotechnology and proposes a number of action steps for government, industry, and other stakeholders.
Source: U.S. Environmental Protection Agency – Publication date: February 2007
EPA's Science Policy Council has issued the Nanotechnology White Paper. The purpose of the White Paper is to inform EPA management of the science issues and needs associated with nanotechnology, to support related EPA program office needs, and to communicate these nanotechnology science issues to stakeholders and the public.
Source: U.S. Food and Drug Administration – Publication date: July 2007
In 2006, the U.S. Food and Drug Administration (FDA) initiated the Nanotechnology Task Force to help assess if emerging nanotechnologies pose questions regarding the adequacy and application of the FDA regulatory guidelines. The Task Force'€™s initial findings were issued in this report.
With the publication of this document, NIOSH hopes to raise awareness of the occupational safety and health practices that should be followed during the synthesis, characterization, and experimentation with engineered nanomaterials in a laboratory setting. The document contains recommendations on engineering controls and safe practices for handling engineered nanomaterials in laboratories and some pilot scale operations. This guidance was designed to be used in tandem with well-established practices and
Source: European Commission Joint Research Centre – Publication date: October 2011
This policy report is the result of the first strategic liaison between the JRC and EASAC and provides independent, cross-referenced, science-based analysis of the impact of nanomaterials on human health. The report is directed at European and national policy-makers and citizens. Nanomaterials have the potential to play a major role in European innovation, economic growth and industrial competitiveness. In order to capitalise on this technology and reap the promised benefits, the EU must ensure the appropriate framework for its success. A key element in this regard concerns a harmonised assessment of the safety of nanomaterials and this requires a strengthened dialogue between policy-makers and scientists.
Source: VDI Technologiezentrum – Publication date: September 2004
The objectives of this report are to assemble available information from public and private sources on changes but also possible hazards involving industrial nanoparticle production, to evaluate the risks for workers, consumers and the environment, and to give recommendations for setting up regulatory measures and codes of good practice.
Source: International Risk Governance Council – Publication date: June 2006
This White Paper is the first in which the IRGC publish recommendations for the risk governance of a particular problem field. The document begins with a brief description of nanotechnology and its likely future development both in terms of research and the types of product that it does and could support. The report categorized nanotechnology in two distinct but overlapping frames, one being for technologies and applications that are already on, or will shortly be available on, the market and the other being for the longer-term. Each of these frames poses a different set of risk governance concerns, although some concerns are common to both frames.
Source: European Commission Scientific Committee on Emerging and Newly Identified Health Risks – Publication date: March 2007
The European Commission asked the independent experts of the Scientific Committee on Emerging and Newly Identified Health Risks (SCENIHR) for a scientific opinion on the appropriateness of existing methodologies to assess the potential risks of nanotechnologies. This report provides this Opinion and the relevant scientific background.
Source: Institute for Agriculture and Trade Policy – Publication date: April 2013
This report reviews a small part of the rapidly growing scientific literature that raises questions about how engineered nanomaterials (ENMs) might affect soil health and soil biodiversity in field trials and subsequently the commercial and chronic application of ENMs in agricultural
soil. The questions concern not only the intentional use of ENMs in fertilizers, but the incidental presence of ENMs in 'biosolids', defined by the U.S. Environmental Protection Agency (EPA) as 'treated residuals from wastewater treatment that can be used beneficially'.